文献速递放疗物理与技术

FLASH与常规剂量率照射对肿瘤和正常组织差异影响的物理化学综合解释

An integrated physico-chemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses.
PubMed 文献 · Radiother Oncol · 2019-04-19

本文基于放射物理、放射化学及肿瘤与正常细胞氧化还原代谢的基本原理,提出一系列可检验的生物学相关假说,以解释FLASH放疗(剂量率超过100 Gy/s)与临床常规剂量率(0.1-0.2 Gy/s)相比,在多种动物模型中显著减轻正常组织并发症而维持对部分肿瘤模型持续生长抑制的差异效应。

要点

  • FLASH放疗采用超过100 Gy/s的剂量率,远高于临床常规的0.1-0.2 Gy/s。
  • FLASH在多种动物模型中显著减轻正常组织并发症,并维持对部分肿瘤模型的生长抑制。
  • 文章基于放射物理、放射化学和氧化还原代谢提出可检验假说解释FLASH差异效应。

核心结论

  • 基于放射物理、放射化学及肿瘤与正常细胞氧化还原代谢的基本原理,提出可检验的生物学相关假说,以合理化FLASH照射在正常组织与肿瘤间观察到的差异效应。

研究设计与样本

  • 本文为基于放射物理、放射化学及肿瘤与正常细胞氧化还原代谢基本原理的假说性文章,未报告系统检索范围或样本量。

主要发现

  • 与临床常规剂量率(0.1-0.2 Gy/s)相比,FLASH可采用超过100 Gy/s的电子或X射线剂量率。
  • 在多种动物模型中,FLASH相比常规剂量率显著减轻正常组织并发症,同时维持对部分肿瘤模型的持续生长抑制。
  • FLASH对正常组织的显著保护作用及对部分肿瘤的生长抑制引发了广泛兴奋与质疑。

临床怎么用

  • 文章提出的可检验假说有助于理解FLASH效应,但未给出临床推荐条款或具体应用方案。

局限性

  • 文章为假说性论述,未报告系统检索范围、样本量或临床研究数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For decades the field of radiation oncology has sought to improve the therapeutic ratio through innovations in physics, chemistry, and biology. To date, technological advancements in image guided beam delivery techniques have provided clinicians with their best options for improving this critical tool in cancer care. Medical physics has focused on the preferential targeting of tumors while minimizing the collateral dose to the surrounding normal tissues, yielding only incremental progress. However, recent developments involving ultra-high dose rate irradiation termed FLASH radiotherapy (FLASH-RT), that were initiated nearly 50 years ago, have stimulated a renaissance in the field of radiotherapy, long awaiting a breakthrough modality able to enhance therapeutic responses and limit normal tissue injury. Compared to conventional dose rates used clinically (0.1-0.2 Gy/s), FLASH can implement dose rates of electrons or X-rays in excess of 100 Gy/s. The implications of this ultra-fast delivery of dose are significant and need to be re-evaluated to appreciate the fundamental aspects underlying this seemingly unique radiobiology. The capability of FLASH to significantly spare normal tissue complications in multiple animal models, when compared to conventional rates of dose-delivery, while maintaining persistent growth inhibition of select tumor models has generated considerable excitement, as well as skepticism. Based on fundamental principles of radiation physics, radio-chemistry, and tumor vs. normal cell redox metabolism, this article presents a series of testable, biologically relevant hypotheses, which may help rationalize the differential effects of FLASH irradiation observed between normal tissue and tumors.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Spitz DR, Buettner GR, Petronek MS, et al. An integrated physico-chemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses. Radiother Oncol. 2019. PMID: 31010709. doi:10.1016/j.radonc.2019.03.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。